IP Verse

Zaklady Farmaceutyczne Polpharma S.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Zaklady Farmaceutyczne Polpharma S.a.

Patent Number:
EP3626270
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
Jul 10, 2024
Patent Number:
EP3542790
Title:
Compositions Comprising A Delivery Agent And Preparation Thereof
Applicant:
NOVO NORDISK A/S
Opposition Date:
Jun 13, 2024
Patent Number:
EP3110449
Title:
Medical Use Of A Dpp-4 Inhibitor
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Mar 26, 2024
Patent Number:
EP3488857
Title:
Compositions Of Glp-1 Peptides And Preparation Thereof
Applicant:
NOVO NORDISK A/S
Opposition Date:
Mar 7, 2024
Patent Number:
EP3294283
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
NOVARTIS AG
Opposition Date:
Dec 7, 2023
Patent Number:
EP2981255
Title:
Therapeutic Uses Of Empagliflozin
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Jun 8, 2023
Patent Number:
EP2849754
Title:
A Xanthine Derivative As Dpp-4 Inhibitor For Use In The Treatment Of Sirs And/Or Sepsis
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Jun 5, 2023
Patent Number:
EP2397142
Title:
Use Of Dpp Iv Inhibitors
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Apr 19, 2023
Patent Number:
EP2986304
Title:
Pharmaceutical Composition, Methods For Treating And Uses Thereof
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Oct 12, 2022
Patent Number:
EP2667856
Title:
Medical Device Containing A Cake Composition Comprising Aripiprazole As An Active Ingredient, And A Cake Composition Comprising Aripiprazole As An Active Ingredient
Applicant:
OTSUKA PHARMACEUTICAL CO., LTD.
Opposition Date:
Apr 27, 2022

Competitors of Zaklady Farmaceutyczne Polpharma S.a.

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY

Want to track Zaklady Farmaceutyczne Polpharma S.a.?

Feel free to send us a message here and we will get back to you